跳至主要内容
临床试验/CTRI/2018/02/011868
CTRI/2018/02/011868已完成未知

Evaluation of appropriateness and pharmacoeconomics of surgical antimicrobial prophylaxis in open reduction internal fixation surgery based on NCDC guidelines

KIMS hospital0 个研究点目标入组 412 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
KIMS hospital
入组人数
412

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • closed fracture cases of more than 18 years of age, irrespective of gender, who were posted for ORIF surgery

排除标准

  • Cases unwilling to give informed consent, open fracture, cases posted for delayed primary or secondary closure procedures, cases already receiving antimicrobials

研究者

发起方
KIMS hospital

相似试验

招募中
4 期
To evaluate the efficacy, safety and pharmacoeconomics of Shiwei Longdanhua capsule in the treatment of acute tracheo-bronchitis (phlegm-heat obstructing lung syndrome)Acute tracheobronchitis
ITMCTR2200006863The Second Affiliated Hospital of Tianjin University of Chinese Medicine
尚未招募
Unknown
pharmacoeconomic evaluation of antidiabetic drugs
CTRI/2023/07/055043Deeksha M
进行中(未招募)
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings - PRO.WIpatients with severe inherited VWD unresponsive to DDAVP and with frequent bleedingsMedDRA version: 8.1Level: PTClassification code 10047715Term: Von Willebrand's disease
EUCTR2006-001383-23-ITFONDAZIONE CENTRO EMOFILIA E TROMBOSI ANGELO BIANCHI BONOMI24
进行中(未招募)
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings.Severe, inherited von Willebrand disease (VWD) and frequent bleedingsMedDRA version: 14.1 Level: PT Classification code 10047715 Term: Von Willebrand's disease System Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2006-001383-23-GBProf Flora Peyvandi, MD24
进行中(未招募)
1 期
Efficacy, safety and pharmaco-economic assessment ofsecondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWDand frequent bleedingsPatients with severe, inherited Von Willebrand’s disease and frequent bleedingsMedDRA version: 16.0Level: PTClassification code 10047715Term: Von Willebrand's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2006-001383-23-DEFondazione IRCCS Cà Granda Ospedale Maggiore Policlinico24